Aktuellt
SENASTE
Redeye makes nothing more than minor short-term estimate changes following Acconeer's Q1 report, meaning no effect on the valuation. We believe Q1 was a turning point and that the coming easy comparables make it possible for Acconeer to report sales growth of about 100% for all remaining quarters of 2024.
LÄS MER
